CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
Following closing of the transaction, which is expected by midyear, the acquired entities will be fully integrated into Roche Diagnostics. The transaction is subject to certain conditions including antitrust and regulatory approvals.
Pages: 1 2
Following closing of the transaction, which is expected by midyear, the acquired entities will be fully integrated into Roche Diagnostics. The transaction is subject to certain conditions including antitrust and regulatory approvals.